For Biotechs and Pharma professionals

OncoDNA solutions solve problems faced by Pharma with a high level of customization depending on your needs

We understand, Biotechs, Biopharma, and CRO companies are grappling with managing an ever-increasing amount of complex data. At OncoDNA, our mission is to provide unwavering support throughout the entire journey, from drug development to marketed drug, offering an extensive portfolio of products and services tailored to meet your needs.

Pharma professionals can rely on our extensive expertise to access and interpret genomic data for clinical studies

Ensuring high-quality standards in clinical trials

Transitional studies

Providing researchers with molecular evidence and accurate insights into data at the transitional stage

We assist biopharma companies in the following:

Validation of biomarkers
Identification of response Predictors
Drug development optimization
Informing regulatory decisions

Phase I-III Clinical Trials

Assisting biopharma companies from the early phase I to phase III by testing and assessing real-world patients

We assist biopharma companies in the following:

Phase I

Early detection of biomarkers
Patient enrollment
Patient stratification
Safety assessment

Phase II

Confirmation of biomarker validity
Treatment response monitoring
Refinement of companion diagnostics

Phase III

Real-Time Monitoring of Biomarkers

impact of genomic profiling on drug development

Licensed drugs

Conducting Post-marketing studies to evaluate the long-term effects of the drug after the medicine has received regulatory approval (market authorization)

We assist biopharma companies in the following:

Long-term safety monitoring
Monitoring of resistance and relapse
Real-world effectiveness studies

Transitional studies

Phase I-III Clinical Trials

Licensed drugs

Study Design

Our experts help your company in answering important questions such as sample timing, sample to be collected...

By leveraging Oncodna Solutions' expertise, pharmaceutical companies can design studies with enhanced precision and efficacy. We can stratify patient cohorts based on molecular profiles, enabling more targeted enrollment and facilitate the identification of predictive biomarkers for treatment response.

Logistics

Full support for sample collection & specimen shipment with global capabilities

Logistics in clinical trials encompass a range of activities that are essential for the successful planning, execution, and completion of a study. Efficient logistics contribute to the reliability of study results, participant safety, and overall trial success.

Communication

Transparent engagement plans focused on collaborative problem solving

Due to the large amount of data, OncoDNA provides biopharma companies with insight via our visualization platform where data is integrated, curated, validated and thus reliable.

Quality Control

Focused on managing relevant quality standards for your project

Our approach encourages a collective effort in overcoming obstacles, enhances the quality of research outcomes, and ultimately contributes to advancing medical knowledge and improving patient outcomes.

Analysis & Report

Easy to use reporting tools to provide you with the data you need to evidence your project

We closely monitor and validate the quality of our data, OncoDNA ensures potential issues are promptly identified and resolved, maintaining the credibility of the study.

CLIA-CAP laboratory that meets regulatory requirements for your trials

Based in France our laboratory is CLIA-certified and CAP-accredited, evidencing our commitment to delivering diagnostic services of the highest caliber. Achieving Clinical Laboratory Improvement Amendments (CLIA) certification and College of American Pathologists (CAP) accreditation places us at the forefront of precision and reliability in clinical testing.

Insight into your oncology data

From individual patient...

...to global visualization

Over the past decade, there has been a rapid acceleration in the innovation of cancer diagnostics, treatments, and patient management. As a result of this acceleration is the generation of a large amount of data. When data is linked, it has the potential to provide oncology experts such as laboratories and pharma companies with comprehensive insights, enabling data-driven decision-making.